CompletedPhase 3NCT00006401
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Studying Bronchopulmonary dysplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Colorado, Denver
- Principal Investigator
- John P. Kinsella, MD, MDChildren's Hospital Medical Center, Cincinnati
- Intervention
- iNO(drug)
- Enrollment
- 793 enrolled
- Eligibility
- 1 years · All sexes
- Timeline
- 2000 – 2007
Study locations (14)
- St. Joseph's Hospital, Phoenix, Arizona, United States
- Loma Linda University Medical Center, Loma Linda, California, United States
- Univeristy of Southern California/Good Samaritan Hospital, Los Angeles, California, United States
- Children's Hospital, Denver, Colorado, United States
- University of Connecticut Health Center, Farmington, Connecticut, United States
- University of Iowa Hospital & Clinics, Iowa City, Iowa, United States
- University of North Carolina Chapel Hill, Chapel Hill, North Carolina, United States
- Duke University Medical Center, Durham, North Carolina, United States
- Children's Hospital of Oklahoma, Oklahoma City, Oklahoma, United States
- Pennsylvania Hospital, Philadelphia, Pennsylvania, United States
- Magee-Women's Hospital, Pittsburgh, Pennsylvania, United States
- Medical University of South Carolina, Charleston, South Carolina, United States
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
- Utah Valley Regional Medical Center, Provo, Utah, United States
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00006401 on ClinicalTrials.govOther trials for Bronchopulmonary dysplasia
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07109791National Surveillance and Prevention of Neonatal VAPUniversity of Alberta
- RECRUITINGNANCT06373289Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm InfantsUniversity of Alabama at Birmingham
- RECRUITINGPHASE2NCT07561125Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and BelowInternational Peace Maternity and Child Health Hospital
- RECRUITINGPHASE2NCT06915441Lipid Infusions to Optimize Nutrition TrialThe University of Texas Health Science Center, Houston
- RECRUITINGPHASE1, PHASE2NCT07101640PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary DysplasiaDuke University
- RECRUITINGNCT07273643Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and MortalityUniversity Hospital, Montpellier
- RECRUITINGEARLY PHASE1NCT07120971Metformin for Premature Infants With Bronchopulmonary DysplasiaMedical College of Wisconsin
- RECRUITINGPHASE1NCT06589245Inhaled Ciclesonide Study in Preterm InfantsVenkatesh Sampath